<DOC>
	<DOCNO>NCT02785887</DOCNO>
	<brief_summary>This randomized parallel group trial design evaluate impact implement geriatrician-prescribed intervention base comprehensive geriatric assessment ( CGA ) , ability deliver adequate chemotherapy treatment , measure relative dose intensity ( RDI ) .</brief_summary>
	<brief_title>Impact Geriatrician Interventions Chemotherapy Delivery Vulnerable Elderly Oncology Patients</brief_title>
	<detailed_description>This randomized parallel group trial design evaluate impact implement geriatrician-prescribed intervention , ability deliver adequate chemotherapy treatment , measure RDI least 85 % , cohort vulnerable [ ≥1 deficit identify CGA and/or ≥1 comorbidity Grade 3-4 define Cumulative Illness Rating Scale Geriatrics ( CIRS-G ) ] elderly cancer patient early stage advance solid organ malignancy . Patients randomize use 2:1 allocation Arm A : routine oncological care plus geriatric intervention Arm B : routine oncological care</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<mesh_term>Urinary Bladder Neoplasms</mesh_term>
	<mesh_term>Gastrointestinal Neoplasms</mesh_term>
	<criteria>1 . Any solid tumor 2 . Either early stage disease plan treatment neo/adjuvant chemotherapy , metastatic disease plan treatment chemotherapy ≤ 1 previous chemotherapy treatment metastatic set 3 . Absence symptomatic central nervous system ( CNS ) metastases 4 . Eastern Cooperative Oncology group ( ECOG ) performance status 02 5 . Estimated life expectancy ≥ 12 week 6 . At least 1 deficit identify CGA screening/baseline , and/or least one comorbidity grade 3 4 severity , define CIRSG 7 . Written inform consent accord International Conference Harmonisation technical requirement registration pharmaceutical human use/Good Clinical Practice ( ICH/GCP ) , national/local ethic regulation 8 . Absence psychological , familial , sociological geographical condition potentially hamper compliance trial protocol followup schedule 1 . Age ≤ 69 year 2 . Any patient meet inclusion criterion</criteria>
	<gender>All</gender>
	<minimum_age>70 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Breast cancer</keyword>
	<keyword>lung cancer</keyword>
	<keyword>Gastrointestinal Cancer</keyword>
	<keyword>Ovarian cancer</keyword>
	<keyword>Prostate cancer</keyword>
	<keyword>bladder cancer</keyword>
</DOC>